MyoKardia Readies First-Ever Hypertrophic Cardiomyopathy Drug For US Filing

 
• By Mandy Jackson

The Phase III EXPLORER-HCM trial evaluating mavacamten in obstructive hypertrophic cardiomyopathy (oHCM) succeeded on all primary and secondary endpoints.

heart surround with pharmaceutical medicine pills and tablets, a flask and a pill box on blue background, heart health and treatment. top view. health concept
MyoKardia's once-daily pill bested placebo on all efficacy measures • Source: Shutterstock

More from Clinical Trials

More from R&D